feed,title,long_url,short_url
Benzinga,Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level,https://benzinga.com/general/biotech/23/12/36385795/oncternal-therapeutics-reports-patient-death-in-mid-stage-blood-cancer-study-treated-with-second-,https://da.gd/qeffNW
